The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
The efficacy of semax in the tretament of patients at different stages of ischemic stroke
Abstract
AIM: To evaluate the efficacy of semax and timing of rehabilitation on the dynamics of plasma BDNF levels, motor performance, and Barthel index score in patients after ischemic stroke (IS). MATERIAL AND METHODS: One hundred and ten patients after IS (43 men, 67 women, mean age 58.0±9.7, Ме 63 years) were examined. All patients were divided into early (89±9 days) and late (214±22 days) rehabilitation groups. Each group was subdivided into semax+ and semax- subgroups. Standard regimen of semax included 2 courses (6000 mcg/day) for 10 days with 20 day interval. Plasma BDNF levels, motor performance on the British Medical Research Council scale and Barthel index were assessed in all groups. RESULTS: Administration of semax, regardless of the timing of rehabilitation, increased BDNF plasma levels which remained high during the whole study period. In semax- subgroups high BDNF plasma levels were positively correlated with early rehabilitation. Administration of semax and high BDNF levels accelerated the improvement and ameliorated the final outcome of Barthel score index. There was a positive correlation between BDNF plasma levels and Barthel score, as well as a correlation between early rehabilitation and motor performance improvement. The correlation between BDNF plasma levels and Barthel score was modified by the timing of rehabilitation. CONCLUSION: Early rehabilitation and administration of semax increase BDNF plasma level, speed functional recovery, and improve motor performance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The peptide drug Semax has a pronounced neuroprotective effect in the treatment of cerebrovascular insufficiency and acute cerebral stroke [8,24,25,26].”
From Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4–7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia–Reperfusion (2021) · cites this paper as [8]
Citations
Cites
(1965) · PubMed · Cited by 14,925
Functional evaluation : Barthel index
Mahonery, F. I. (1965) · Medical Entomology and Zoology · Cited by 12,762
Atorvastatin Induction of VEGF and BDNF Promotes Brain Plasticity after Stroke in Mice
Chen, J., Zhang, C., Jiang, H., Li, Y., Zhang, L., Robin, A., Katakowski, M., Lu, M., & Chopp, M. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600034 · Cited by 449
Ploughman, M., Windle, V., MacLellan, C. L., White, N., Doré, J. J., & Corbett, D. (2009) · Stroke · doi:10.1161/strokeaha.108.531806 · Cited by 362
Ke, Z., Yip, S. P., Li, L., Zheng, X.-X., & Tong, K.-Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016643 · Cited by 280
Nettekoven, C., Volz, L. J., Kutscha, M., Pool, E.-M., Rehme, A. K., Eickhoff, S. B., Fink, G. R., & Grefkes, C. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4993-13.2014 · Cited by 264
Luengo-Fernandez, R., Paul, N. L. M., Gray, A. M., Pendlebury, S. T., Bull, L. M., Welch, S. J. V., Cuthbertson, F. C., & Rothwell, P. M. (2013) · Stroke · doi:10.1161/strokeaha.113.001584 · Cited by 259
Kantak, S. S., Stinear, J. W., Buch, E. R., & Cohen, L. G. (2012) · Neurorehabilitation and Neural Repair · doi:10.1177/1545968311420845 · Cited by 245
Gray, J. D., Milner, T. A., & McEwen, B. S. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.08.034 · Cited by 244
Miyamoto, N., Maki, T., Shindo, A., Liang, A. C., Maeda, M., Egawa, N., Itoh, K., Lo, E. K., Lok, J., Ihara, M., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1592-15.2015 · Cited by 239
Research works printed but not linked: 5
- Gusev EI, Skvortsova VI, Martynov MYu. Tserebralnyi insult: problemy i reshenia. Vestnik Rossiiskoi akademii nauk. 2003;11(4):44-48. (In Russ.)
- Kamensky AA, Myasoedov NF, Levitskaya NG, Andreeva LA, Sebentsova EA, Glazova NYu, Vilensky DA, Manchenko DM. Issledovanie spektra fiziologicheskoi aktivnosti analoga AKTG 4-10 geptapeptida Semaks. Neirokhimia. 2008;25(1-2):111-118. (In Russ.)
- Raevsky KS, Kudrin VS, Myasoedov NF, Grivennikov IA, Andreeva LA, Eremin KO. Vliyanie Semaksa na soderzhanie i obmen monoaminov v mozge myshei linii C57/BL. Neirokhimia. 2002;19(3):202-205. (In Russ.)
- Myasoedov NF, Skvorcova VI, Nasonov EL, ZHuravleva EYU, Grivennikov IA, Arsen'eva EL, Suhanov II. Izuchenie mekhanizmov nejroprotektivnogo dejstviya semaksa v ostrom periode ishemicheskogo insul'ta. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 1999;99(5):15-19. (In Russ.)
- Limborskaya SA, Shadrina MI, Slominskij PA, Myasoedov NF, Shram SI, Silachev DN, Agapova TYu, Agniullin YaV. Vremennaya dinamika ehkspressii genov nejrotroficheskogo faktora mozga i faktora rosta nervov v gippokampe i lobnoj kore krys pod dejstviem Semaksa. Molekulyarnaya genetika, mikrobiologiya i virusologiya. 2008;3:28-31. (In Russ.)
Cited by
Ridaura, I. E., Sorrentino, S., & Moroni, L. (2021) · Advanced Science · doi:10.1002/advs.202101837 · Cited by 52
Neuroprotective Peptides and New Strategies for Ischemic Stroke Drug Discoveries
Dergunova, L. V., Filippenkov, I. B., Limborska, S. A., & Myasoedov, N. F. (2023) · Genes · doi:10.3390/genes14050953 · Cited by 34
“Semax has been used in neurological practice for many years in the treatment of acute and chronic disorders, including IS and its consequences [89,90].”
BackgroundFilippenkov, I. B., Stavchansky, V. V., Denisova, A. E., Yuzhakov, V. V., Sevan’kaeva, L. E., Sudarkina, O. Y., Dmitrieva, V. G., Gubsky, L. V., Myasoedov, N. F., Limborska, S. A., et al. (2020) · Genes · doi:10.3390/genes11060681 · Cited by 29
Neuroprotective Effects of Tripeptides—Epigenetic Regulators in Mouse Model of Alzheimer’s Disease
Khavinson, V. K., Ilina, A., Kraskovskaya, N., Linkova, N. S., Колчина, Н. В., Mironova, E. S., Erofeev, A., & Petukhov, M. (2021) · Pharmaceuticals · doi:10.3390/ph14060515 · Cited by 19
“Semax has nootropic, psycho-stimulating, antioxidant and antihypoxic effects [22–25].”
Sudarkina, O. Y., Filippenkov, I. B., Stavchansky, V. V., Denisova, A. E., Yuzhakov, V. V., Sevan’kaeva, L. E., Valieva, L. V., Remizova, J. A., Dmitrieva, V. G., Gubsky, L. V., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126179 · Cited by 15
“Without hormonal and toxic side effects, the peptide increases the rate and extent of recovery of neurological functions [8], reduces the severity of neurological deficits, and prolongs the survival of animals with ischemic stroke [9].”
Background
Metadata
- Authors
- Gusev, E. I., Martynov, M. Y., Kostenko, E. V., Petrova, L. V., & Bobyreva, S. N.
- Affiliations
- Pirogov Russian National Research Medical University (RU)
- Venue
- Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova
- Publisher
- Media Sphere Publishing House
- Published
- 2018
- Volume
- 118
- Issue
- 3
- Pages
- 61
- ISSN
- 1997-7298 (ISSN-L)
- OpenAlex
- W2803355579
- Cited by
- 24
- References
- 26
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 5 · 2023: 3 · 2022: 3 · 2021: 8 · 2020: 1 · 2019: 1
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- S S Korsakov Journal of Neurology and Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- Semax, ischemic stroke, brain-derived neurotrophic factor, early rehabilitation, rehabilitation timing, motor performance, functional recovery, Barthel Index, plasma BDNF levels, stroke rehabilitation
- MeSH terms
- Stroke Rehabilitation, Adrenocorticotropic Hormone, Aged, Brain Ischemia, Female, Humans, Male, Middle Aged, Peptide Fragments, Brain-Derived Neurotrophic Factor, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The efficacy of semax in the tretament of patients at different stages of ischemic stroke. https://app.cochat.ai/papers/10.17116/jnevro20181183261-68
- The paper
- Gusev, E. I., Martynov, M. Y., Kostenko, E. V., Petrova, L. V., & Bobyreva, S. N. (2018). The efficacy of semax in the tretament of patients at different stages of ischemic stroke. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. https://doi.org/10.17116/jnevro20181183261-68
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.